COMMUNIQUÉS West-GlobeNewswire

PharmAla Announces Changes to Board of Directors
10/02/2026
TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
10/02/2026
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that it has granted to Dr. Minako Pazdera, the new General Counsel of LB [...]
Avicanna Announces Closing of Non-Brokered Private Placement
10/02/2026
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, Feb. 10 [...]
Blueroot Health Appoints Jay Schwartz CEO as North Castle Backs Next Phase of Practitioner-Focused Growth
10/02/2026
MIDDLETOWN, Conn., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Blueroot Health , a consumer health company focused on advancing long-term health and well-being for people and the planet, today announced the appointment of Jay [...]
Upstream Bio to Host Webcast to Report Top-Line Results from the Phase 2 VALIANT Trial of Verekitug in Patients with Severe Asthma
11/02/2026
– Webcast to be held Wednesday, February 11, 2026, at 8:00 a.m. ET – WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory [...]
Newsweek Names Chicago Plastic Surgeons Best in America for 11 Procedures
10/02/2026
CHICAGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Board-certified plastic surgeons Thomas Mustoe, MD , and Sammy Sinno, MD , of TLKM Plastic Surgery, have been recognized by Newsweek as two of America’s Best Plastic Surgeons [...]
Miami Startup Launches First At-Home Gut Test Designed Specifically for Cognitive Wellness
10/02/2026
Cervco's Gut-Brain Wellness Test helps adults monitor bacteria and lifestyle factors that research links to cognitive wellness—no doctor's prescription required MIAMI, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Cervco, a [...]
Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation
10/02/2026
Approval Marks Final Regulatory Milestone Required to Enable Launch of Upstream Manufacturing Activities Under New Offshored & Outsourced Production Model Expected to Drive Gross Margin Expansion, Improve Working [...]
Nebraska Remains a National Outlier in Certified Nurse-Midwife Regulation
10/02/2026
Examining Nebraska’s Certified Nurse-Midwife regulations following stalled legislative reform LINCOLN, NE,, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Nebraska regulates Certified Nurse-Midwives differently than nearly every [...]
Hassan Spine & Sports Medicine Rebrands as NefraHealth
10/02/2026
New Identity Reflects Patient-First Philosophy, Practice Growth Board-Certified Spine Surgeon Joins Growing Central Jersey Practice OLD BRIDGE, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Hassan Spine & Sports Medicine [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026
10/02/2026
Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2026
10/02/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
IBA – ACQUISITION OF OWN SHARES
10/02/2026
Louvain-la-Neuve, Belgium, February 10 th , 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA [...]
IBA – ACQUISITION D’ACTIONS PROPRES
10/02/2026
Louvain-la-Neuve, Belgique, 10 février 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") [...]
Hyagen Medical Launches National FDA Compliance and Education Initiative to Strengthen Regenerative Medicine Standards
10/02/2026
FDA-aligned education and compliance for ethical stem cell and regenerative medicine practices Lehi, UT, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Hyagen Medical , a regulatory compliance and education company specializing in [...]
Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition
10/02/2026
ORLANDO, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCID: MAJI) , a clinical-stage biotechnology company specializing in proprietary exosome-based delivery systems, is pleased to announce a significant [...]
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System
10/02/2026
CLEARWATER, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- via IBN – MedWell Ai, Inc ("Company") (OTCQB: MWAI) is pleased to announce the signing of a Letter of Intent (“LOI”) to create a vertically integrated health, wellness [...]
BioAro Secures UAE Approval for AI-Enabled Longevity Bioactives, Setting the Stage for Global Expansion
10/02/2026
DUBAI, United Arab Emirates and TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- BioAro Inc. , a biotechnology company at the forefront of precision health and longevity, has achieved a major milestone with regulatory [...]
BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart
10/02/2026
SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported it [...]

Pages